Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
hERGscreen - hERG related risk assessment of botanicals
Third-party funded project
Project title hERGscreen - hERG related risk assessment of botanicals
Principal Investigator(s) Hamburger, Matthias
Organisation / Research unit Departement Pharmazeutische Wissenschaften / Pharmazeutische Biologie (Hamburger)
Project start 01.03.2012
Probable end 29.02.2016
Status Completed
Abstract

The main goal of this project is the establishment of a network between European, South American, North American and South African educational and research entities. This attempt will be based on an innovative scientific project aiming towards the identification of hERG (human Ether-à-go-go Related Gene) channel blockers in commonly consumed botanicals and supplements. Blocking these ion channels may result in ventricular tachyarrhythmia and an increased incidence of sudden death. Thus, the hERG channel is considered as an important antitarget. Several drugs have been removed from the market for this reason, and compounds have been blocked from proceeding further into phases of clinical development. As botanicals (comprising dietary supplements, spices, herbal medicinal products) continue to increase in popularity there is an urgent need for studies aimed to critically assess the potential cardiotoxic risks of these products.

State-of-the-art methodologies and techniques will be incorporated for target-oriented identification and isolation of hERG channel blocking constituents. PK and PD studies will be performed and LC-MS based methods will be developed and applied towards the measurement of bioactive components in biofluids samples. Comparison of biofluids derived from administration of single chemical entities and corresponding botanicals will be achieved using MS- and NMR-based metabolomics. The obtained results will help to elaborate and evaluate hERG related safety aspects aiming towards the risk assessment of frequently consumed botanicals.

Within this frame numerous short term and extended secondments of scientific staff will be accomplished, while the organization of several workshops will assure the proper dissemination of the produced knowledge throughout all the scientific community but also the public. Core scientific knowledge is expected to be produced and exchanged, and partnerships with future scientific potentials to be created.

Financed by Commission of the European Union

Cooperations ()

  ID Kreditinhaber Kooperationspartner Institution Laufzeit - von Laufzeit - bis
169725  Hamburger, Matthias  Steffen Hering, Prof.  University of Vienna, Pharmacenter, Institute of Pharmacology and Toxicology  13.01.2007  31.12.2012 
470279  Hamburger, Matthias  Skaltsounis Leandros, Prof.  University of Athens, Faculty of Pharmacy  16.02.2009  31.12.2013 
   

MCSS v5.8 PRO. 0.432 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
26/04/2024